BOLD Boundless Bio, Inc.

Fundamentals / CIK 0001782303 / USD

Boundless Bio, Inc. reported $63.59M in total assets and a net loss of $55.50M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BOLD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$61.11MFY 2023 Net Income: -$49.43M2023FY 2024 Net Income: -$65.36M2024FY 2025 Net Income: -$58.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $44.84M $55.27M $42.64M
Total Operating Expenses $63.55M $73.27M $54.80M
Operating Income -$63.55M -$73.27M -$54.80M
EBITDA -$62.30M -$72.18M -$53.84M
Interest Income $5.36M $7.89M $5.28M
Income Tax Expense $0 $0 --
Net Income -$58.20M -$65.36M -$49.43M
Basic EPS -$2.60 -$3.85 -$40.65
Diluted EPS -$2.60 -$3.85 -$40.65
Basic Shares Outstanding 22.4M 17.0M 1.2M
Diluted Shares Outstanding 22.4M 17.0M 1.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.44M $13.97M $9.73M $9.82M $10.67M $12.22M $12.14M $13.31M
Total Operating Expenses $6.20M $24.38M $14.47M $14.00M $15.15M $17.06M $17.34M $18.28M
Operating Income -$6.20M -$24.38M -$14.47M -$14.00M -$15.15M -$17.06M -$17.34M -$18.28M
EBITDA -$6.10M -$23.13M -$14.19M -$13.70M -$14.84M -$16.74M -$17.02M -$17.98M
Interest Income $572K $690K $920K $1.12M $1.27M $1.39M $1.58M $1.92M
Net Income -$5.36M -$23.69M -$13.55M -$12.88M -$13.88M -$15.68M -$15.76M -$16.45M
Basic EPS -$0.23 -$1.06 -$0.60 -- -$0.62 -$0.70 -$0.71 --
Diluted EPS -$0.23 -$1.06 -$0.60 -- -$0.62 -$0.70 -$0.71 --
Basic Shares Outstanding 22.9M 22.4M 22.4M -- 22.4M 22.4M 22.3M --
Diluted Shares Outstanding 22.9M 22.4M 22.4M -- 22.4M 22.4M 22.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $17.87M $26.59M $23.71M
Short-Term Investments $89.71M $125.5M $97.05M
Cash & Short-Term Investments $107.6M $152.1M $120.8M
Total Current Assets $109.6M $154.4M $124.2M
Property, Plant & Equipment, Net $3.22M $4.32M $2.57M
Total Non-Current Assets $47.45M $52.02M $5.69M
Total Assets $157.1M $206.4M $129.9M
Accounts Payable $1.49M $1.27M $2.22M
Total Current Liabilities $12.54M $8.13M $9.36M
Total Non-Current Liabilities $45.87M $47.63M $0
Total Liabilities $58.41M $55.77M $9.36M
Total Debt (incl. Leases) $49.03M $47.63M $2.19M
Common Stock $2.0K $2.0K $0
Retained Earnings -$259.7M -$201.5M -$136.1M
Accumulated Other Comp. Income $64K $121K $40K
Total Stockholders' Equity $98.65M $150.6M -$127.1M
Total Equity $98.65M $150.6M -$127.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $34.91M $20.21M $17.48M $17.87M $14.98M $14.70M $15.12M $26.59M
Short-Term Investments $27.98M $52.41M $75.36M $89.71M $102.6M $112.5M $123.1M $125.5M
Cash & Short-Term Investments $62.90M $72.60M $92.80M $107.6M $117.6M $127.1M $138.3M $152.1M
Total Current Assets $63.59M $73.65M $94.62M $109.6M $120.2M $129.7M $140.4M $154.4M
Property, Plant & Equipment, Net $0 $97K $2.94M $3.22M $3.50M $3.79M $4.08M $4.32M
Total Non-Current Assets $0 $97K $46.35M $47.45M $48.56M $49.76M $50.88M $52.02M
Total Assets $63.59M $73.74M $141.0M $157.1M $168.7M $179.5M $191.2M $206.4M
Accounts Payable $814K $1.05M $2.04M $1.49M $1.14M $2.29M $1.37M $1.27M
Total Current Liabilities $1.87M $7.77M $9.58M $12.54M $11.85M $9.21M $6.34M $8.13M
Total Non-Current Liabilities $0 $0 $45.00M $45.87M $46.71M $47.55M $48.31M $47.63M
Total Liabilities $1.87M $7.77M $54.59M $58.41M $58.55M $56.76M $54.65M $55.77M
Total Debt (incl. Leases) -- -- $48.29M $49.03M $49.76M $49.51M $48.57M $47.63M
Common Stock $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$302.3M -$296.9M -$273.2M -$259.7M -$246.8M -$232.9M -$217.2M -$201.5M
Accumulated Other Comp. Income -$19K -$32K -$23K $64K $50K -$4.0K $32K $121K
Total Stockholders' Equity $61.72M $65.98M $86.38M $98.65M $110.2M $122.7M $136.6M $150.6M
Total Equity $61.72M $65.98M $86.38M $98.65M $110.2M $122.7M $136.6M $150.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$58.20M -$65.36M -$49.43M
Depreciation & Amortization $1.25M $1.09M $957K
Stock-Based Compensation $6.12M $7.52M $3.34M
Operating Cash Flow -$46.66M -$60.84M -$46.85M
Capital Expenditure -$546K -$2.54M -$633K
Free Cash Flow -$47.21M -$63.38M -$47.49M
Purchases of Investments -$174.9M -$208.5M -$160.1M
Sales & Maturities of Investments $213.2M $184.9M $122.5M
Investing Cash Flow $37.80M -$26.10M -$38.26M
Financing Cash Flow $141K $89.82M $97.90M
Net Change in Cash -$8.72M $2.88M $12.78M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.36M -$23.69M -$13.55M -$12.88M -$13.88M -$15.68M -$15.76M -$16.45M
Depreciation & Amortization $97K $1.26M $284K $307K $310K $317K $317K $296K
Stock-Based Compensation $284K $3.22M $1.37M $1.33M $1.30M $1.69M $1.80M $2.01M
Operating Cash Flow -$10.88M -$20.97M -$14.97M -$10.11M -$10.20M -$11.83M -$14.53M -$15.56M
Capital Expenditure $0 -$38K -$8.0K -$424K -$15K -$48K -$59K -$466K
Free Cash Flow -$10.88M -$21.01M -$14.98M -$10.53M -$10.21M -$11.88M -$14.59M -$16.03M
Purchases of Investments $0 -$8.39M -$29.41M -$39.10M -$39.51M -$43.66M -$52.62M -$47.44M
Sales & Maturities of Investments $24.50M $31.50M $44.00M $52.50M $50.00M $55.00M $55.74M $49.73M
Investing Cash Flow $24.77M $23.07M $14.59M $12.97M $10.48M $11.29M $3.06M $1.82M
Financing Cash Flow -- -- -- -- -- -- -- $113K
Net Change in Cash $14.70M $2.17M -$385K $2.89M $283K -$420K -$11.47M -$13.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -59.0% -43.4% --
Return on Assets (ROA) -37.1% -31.7% -38.1%
Current Ratio 8.74x 18.98x 13.27x
Quick Ratio 8.58x 18.70x 12.90x
Debt to Equity 0.50x 0.32x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -89.9% -97.0% -64.8% -59.0% -56.1% -52.5% -48.1% -43.4%
Return on Assets (ROA) -87.3% -86.8% -39.7% -37.1% -36.6% -35.9% -34.3% -31.7%
Current Ratio 33.97x 9.48x 9.87x 8.74x 10.14x 14.08x 22.15x 18.98x
Quick Ratio 33.60x 9.35x 9.68x 8.58x 9.93x 13.80x 21.82x 18.70x
Debt to Equity -- -- 0.56x 0.50x 0.45x 0.40x 0.36x 0.32x
Source: SEC EDGAR CompanyFacts (CIK 0001782303) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal